Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease

被引:0
作者
Michael Teitcher
Sarah Weinerman
Catharina Whybra
Michael Beck
Nir Sharon
Deborah Elstein
Gheona Altarescu
机构
[1] Shaare Zedek Medical Center,Gaucher Clinic
[2] University of Mainz,Children’s Hospital
[3] School of Public Health,Department of Statistics
[4] Hebrew University,Genetic Unit
[5] Shaare Zedek Medical Center,undefined
来源
Genetica | 2008年 / 134卷
关键词
Fabry disease; Vitamin D receptor; Polymorphisms; Haplotype; Severity score;
D O I
暂无
中图分类号
学科分类号
摘要
Fabry disease, an X-linked inborn error of metabolism, is characterized by multi-organ involvement including cardiac signs of left ventricular hypertrophy and abnormal intima-medial (IMT) thickening of arteries, progressive renal failure, neurological involvement, and more. The vitamin D receptor (VDR) and an enzyme producing vitamin D3 result in an autocrine loop with direct effects on blood vessels. The purpose of this study is to assess VDR polymorphisms (BsmI, FokI, ApaI, and TaqI) relative to clinically important disease parameters using a disease-specific severity score (MSSI) and haplotype analysis. There were statistically significant differences between females (43% of 74 patients) and males in MSSI total scores, and in general and neurologic sub-scores. There appears to be a protective effect of the TaqI tt genotype so that there were significantly lower scores in clinical categories between those with the tt genotype versus those with the TT genotype. Multivariate models of haplotypes with MSSI scores reveal that T-A-f-B and t-a-F-b haplotypes of the VDR gene polymorphisms are significantly associated with variation in the Fabry phenotype. Despite the limitations of using the MSSI score as a clinical correlate, these results are provocative and further studies in larger cohorts with more males are recommended.
引用
收藏
页码:377 / 383
页数:6
相关论文
共 246 条
[1]  
Altarescu G(2004)Cardiac abnormalities in Fabry disease: natural history in hemizygote males suggests that cardiac pathology is universally present Haema 8 103-108
[2]  
Elstein D(2006)Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease Acta Paediatr Suppl 95 63-68
[3]  
Barbey F(2006)Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition Arterioscler Thromb Vasc Biol 26 839-844
[4]  
Brakch N(2001)ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men J Lab Clin Med 137 133-140
[5]  
Linhart A(2002)Arterial remodelling in Fabry disease Acta Paediatr Suppl 91 62-66
[6]  
Jeanrenaud X(1967)Enzymatic defect in Fabry’s disease. Ceramidetrihexosidase deficiency N Engl J Med 276 1163-1167
[7]  
Palecek T(1981)Advances in the treatment of inherited metabolic diseases Adv Hum Genet 11 281-369
[8]  
Bultas J(2005)Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis Pharmacogenet Genomics 15 349-355
[9]  
Burnier M(1997)The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women J Bone Miner Res 12 1043-1048
[10]  
Hayoz D(2006)Structural and functional changes in peripheral vasculature of Fabry patients J Inherit Metab Dis 29 660-666